COM:INARIMEDICAL
Inari Medical
- Stock
Last Close
49.75
22/11 21:00
Market Cap
3.00B
Beta: -
Volume Today
590.81K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 2.52M - | 7.28M 188.32% | 15.82M 117.52% | 26.82M 69.46% | 37.74M 40.73% | ||
average payables | 1.63M - | 2.80M 71.50% | 4.79M 71.34% | 7.10M 48.10% | 9.12M 28.42% | ||
average receivables | 6.77M - | 19.65M 190.51% | 35.18M 78.99% | 50.48M 43.50% | 64.36M 27.50% | ||
book value per share | -1.03 - | -1.02 0.76% | 6.25 712.73% | 4.80 23.19% | 7.89 64.36% | 8.19 3.76% | |
capex per share | -0.02 - | -0.08 317.55% | -0.17 107.99% | -0.27 60.70% | -0.19 31.24% | -0.08 55.95% | |
capex to depreciation | -2.66 - | -5.12 92.60% | -3.94 23.07% | -3.17 19.66% | -1.40 55.87% | -0.44 68.61% | |
capex to operating cash flow | 0.07 - | 0.64 821.40% | -2.86 548.30% | -0.54 81.25% | 0.71 233.03% | -0.13 118.41% | |
capex to revenue | -0.11 - | -0.06 44.23% | -0.04 36.43% | -0.05 26.02% | -0.03 47.32% | -0.01 63.23% | |
cash per share | 0.57 - | 0.62 8.27% | 5.13 731.99% | 3.54 31.04% | 6.18 74.75% | 2.03 67.08% | |
days of inventory on hand | 311.53 - | 244.13 21.63% | 295.12 20.89% | 310.39 5.17% | 267.20 13.91% | 265.09 0.79% | |
days payables outstanding | 203.47 - | 157.40 22.64% | 84.86 46.09% | 96.44 13.64% | 62.81 34.87% | 65.36 4.05% | |
days sales outstanding | 119.16 - | 80.68 32.29% | 73.19 9.28% | 55.81 23.75% | 55.79 0.04% | 51.85 7.06% | |
debt to assets | 0.37 - | 0.44 19.60% | 0.09 - | 0.06 31.69% | 0.05 25.78% | ||
debt to equity | -0.25 - | -0.50 99.57% | 0.12 - | 0.08 36.58% | 0.07 10.97% | ||
dividend yield | |||||||
earnings yield | -0.01 - | -0.00 81.22% | 0.00 521.73% | 0.00 56.11% | -0.01 502.67% | -0.00 94.91% | |
enterprise value | 1.62B - | 1.63B 0.48% | 2.68B 64.86% | 4.48B 67.16% | 3.33B 25.71% | 3.68B 10.47% | |
enterprise value over ebitda | -181.95 - | 1.25K 788.33% | 147.03 88.26% | 408.30 177.70% | -177.41 143.45% | -262.19 47.78% | |
ev to operating cash flow | -148.64 - | -329.59 121.74% | 1.40K 525.59% | 175.91 87.46% | -238.36 235.51% | 102.40 142.96% | |
ev to sales | 237.08 - | 31.82 86.58% | 19.20 39.65% | 16.19 15.71% | 8.68 46.34% | 7.45 14.19% | |
free cash flow per share | -0.30 - | -0.21 30.61% | -0.11 47.41% | 0.24 314.61% | -0.45 290.48% | 0.55 221.45% | |
free cash flow yield | -0.01 - | -0.00 30.61% | -0.00 74.39% | 0.00 305.25% | -0.01 373.52% | 0.01 218.91% | |
graham net net | -1.10 - | -1.29 17.27% | 5.52 526.65% | 2.93 46.84% | 5.67 93.33% | -0.35 106.16% | |
graham number | 2.47 - | 1.07 56.83% | 7.78 628.44% | 4.62 40.63% | 9.92 114.68% | 2.30 76.77% | |
income quality | 1.07 - | 4.14 286.05% | 0.14 96.65% | 2.59 1,767.89% | 0.48 81.57% | -21.96 4,699.99% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.54 Infinity% | |
interest coverage | -10.30 - | 0.87 108.45% | 16.23 1,763.69% | 22.62 39.37% | -95.57 522.58% | 71.59 174.91% | |
interest debt per share | 0.28 - | 0.53 90.25% | 0.04 93.34% | 0.59 1,571.40% | 0.62 4.12% | 0.56 9.01% | |
inventory turnover | 1.17 - | 1.50 27.61% | 1.24 17.28% | 1.18 4.92% | 1.37 16.16% | 1.38 0.80% | |
invested capital | -0.25 - | -0.50 99.57% | 0.12 - | 0.08 36.58% | 0.07 10.97% | ||
market cap | 1.63B - | 1.63B 0% | 2.80B 71.44% | 4.55B 62.60% | 3.36B 26.14% | 3.69B 9.74% | |
net current asset value | -40.38M - | -44.28M 9.66% | 191.84M 533.21% | 172.87M 9.89% | 335.75M 94.23% | 26.24M 92.19% | |
net debt to ebitda | 1.35 - | -3.20 337.44% | -6.26 95.60% | -5.79 7.58% | 1.49 125.71% | 0.47 68.63% | |
net income per share | -0.26 - | -0.05 81.22% | 0.43 965.98% | 0.20 54.11% | -0.55 380.42% | -0.03 94.80% | |
operating cash flow per share | -0.28 - | -0.13 54.68% | 0.06 146.40% | 0.51 757.15% | -0.26 151.69% | 0.63 339.32% | |
payables turnover | 1.79 - | 2.32 29.27% | 4.30 85.49% | 3.78 12.01% | 5.81 53.53% | 5.58 3.90% | |
receivables turnover | 3.06 - | 4.52 47.70% | 4.99 10.23% | 6.54 31.15% | 6.54 0.04% | 7.04 7.60% | |
research and ddevelopement to revenue | 0.58 - | 0.14 75.83% | 0.13 6.71% | 0.18 39.82% | 0.19 5.08% | 0.18 8.38% | |
return on tangible assets | -0.38 - | -0.04 88.66% | 0.06 250.44% | 0.03 50.96% | -0.06 283.80% | -0.01 90.88% | |
revenue per share | 0.18 - | 1.33 648.70% | 4.36 227.18% | 5.56 27.52% | 7.26 30.53% | 8.70 19.81% | |
roe | 0.26 - | 0.05 81.07% | 0.07 41.33% | 0.04 40.26% | -0.07 270.62% | -0.00 94.99% | |
roic | 0.30 - | -0.07 121.40% | 0.10 250.34% | 0.02 78.95% | -0.07 415.89% | 0.01 115.67% | |
sales general and administrative to revenue | 1.57 - | 0.73 53.56% | |||||
shareholders equity per share | -1.03 - | -1.02 0.76% | 6.25 712.73% | 4.80 23.19% | 7.89 64.36% | 8.19 3.76% | |
stock based compensation to revenue | 0.04 - | 0.01 72.81% | 0.03 155.55% | 0.09 264.14% | 0.07 18.62% | 0.08 9.29% | |
tangible asset value | -39.45M - | -39.14M 0.76% | 200.25M 611.59% | 239.21M 19.45% | 417.00M 74.33% | 99.69M 76.09% | |
tangible book value per share | -1.03 - | -1.02 0.76% | 6.25 712.73% | 4.80 23.19% | 7.89 64.36% | 1.76 77.75% | |
working capital | 23.84M - | 30.54M 28.11% | 191.84M 528.18% | 202.69M 5.66% | 366.73M 80.94% | 159.22M 56.58% |
All numbers in (except ratios and percentages)